|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.610 USD | +0.23% |
|
-.--% | - |
| 25-09-17 | Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell Microcap Index | CI |
| 25-09-17 | Y-mAbs Therapeutics, Inc.(NasdaqGS:YMAB) dropped from Russell 3000E Index | CI |
Company Valuation: YMAS THER
Data adjusted to current consolidation scope
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,242 | 2,006 | 707.5 | 213.1 | 297.5 | 350.7 |
| Change | - | 61.56% | -64.73% | -69.88% | 39.61% | 17.88% |
| Enterprise Value (EV) 1 | 1,037 | 1,895 | 529.5 | 109.1 | 220.3 | 284.3 |
| Change | - | 82.82% | -72.06% | -79.4% | 101.9% | 29.06% |
| P/E Ratio | -13.6x | -16.6x | -12.7x | -2.23x | -13.9x | -11.7x |
| PBR | 6.24x | 19x | 3.93x | 1.95x | 2.95x | 3.83x |
| PEG | - | -0.6x | 0.2x | -0x | 0.2x | -0.3x |
| Capitalization / Revenue | - | 96,666,562x | 20,273,029x | 3,265,057x | 3,507,462x | 3,999,526x |
| EV / Revenue | - | - | - | - | - | - |
| EV / EBITDA | -12.5x | -15.9x | -4.62x | -1.32x | -10.8x | -11.6x |
| EV / EBIT | -12.5x | -15.8x | -4.59x | -1.31x | -10.4x | -11.3x |
| EV / FCF | -22.4x | -33.2x | -9.22x | -3.86x | -15.7x | 64x |
| FCF Yield | -4.46% | -3.01% | -10.8% | -25.9% | -6.37% | 1.56% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -2.303 | -2.975 | -1.28 | -2.187 | -0.4909 | -0.67 |
| Distribution rate | - | - | - | - | - | - |
| Net sales | - | 20.75 | 34.9 | 65.27 | 84.82 | 87.68 |
| EBITDA 1 | -82.84 | -119.5 | -114.7 | -82.48 | -20.46 | -24.58 |
| EBIT 1 | -83 | -119.9 | -115.4 | -83.32 | -21.19 | -25.11 |
| Net income 1 | -81.03 | -119.3 | -55.28 | -95.57 | -21.43 | -29.67 |
| Net Debt 1 | -204.9 | -110.7 | -177.9 | -104 | -77.22 | -66.41 |
| Reference price 2 | 31.250 | 49.510 | 16.210 | 4.880 | 6.820 | 7.830 |
| Nbr of stocks (in thousands) | 39,728 | 40,514 | 43,644 | 43,668 | 43,622 | 44,789 |
| Announcement Date | 3/12/20 | 3/1/21 | 3/1/22 | 3/30/23 | 2/29/24 | 3/4/25 |
1USD in Million2USD
Estimates
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- YMAB Stock
- Valuation YMAS THER
Select your edition
All financial news and data tailored to specific country editions
